FIBROGEN INC Quarterly Interest Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Fibrogen Inc quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q3 2024.
  • Fibrogen Inc Interest Expense for the quarter ending September 30, 2024 was $4.99M, a 0.56% decline year-over-year.
  • Fibrogen Inc Interest Expense for the twelve months ending September 30, 2024 was $19.8M, a 71.3% increase year-over-year.
  • Fibrogen Inc annual Interest Expense for 2023 was $15.5M, a 979% increase from 2022.
  • Fibrogen Inc annual Interest Expense for 2022 was $1.44M, a 34% increase from 2021.
  • Fibrogen Inc annual Interest Expense for 2021 was $1.08M, a 55.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $19.8M $4.99M -$28K -0.56% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $19.9M $4.78M +$1.71M +55.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $18.2M $5M +$2.62M +111% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $15.5M $5.07M +$3.95M +353% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $11.6M $5.02M +$4.94M +5879% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $6.64M $3.07M +$2.93M +2077% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $3.72M $2.37M +$2.28M +2345% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.44M $1.12M +$1.01M +916% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $432K $84K -$25K -22.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $457K $141K -$214K -60.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $671K $97K -$404K -80.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.08M $110K -$428K -79.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $1.5M $109K -$471K -81.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $1.97M $355K -$296K -45.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $2.27M $501K -$132K -20.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $2.4M $538K -$130K -19.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $2.53M $580K -$122K -17.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.65M $651K -$85K -11.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.74M $633K -$137K -17.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.88M $668K -$2.07M -75.6% Oct 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
Q3 2019 $4.94M $702K -$2.04M -74.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.98M $736K -$2.01M -73.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $8.99M $770K -$2M -72.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $11M $2.73M +$928K +51.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $10.1M $2.74M -$30K -1.08% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $10.1M $2.75M -$7K -0.25% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $10.1M $2.77M +$394K +16.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $9.71M $1.81M -$945K -34.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $10.7M $2.77M +$9K +0.33% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $10.6M $2.76M +$319K +13.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $10.3M $2.38M -$402K -14.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $10.7M $2.75M -$5K -0.18% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $10.7M $2.76M +$2K +0.07% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $10.7M $2.44M -$324K -11.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $11.1M $2.78M +$19K +0.69% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $11M $2.76M -$179K -6.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $11.2M $2.76M +$35K +1.29% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $11.2M $2.76M +$37K +1.36% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $11.1M $2.76M +$32K +1.17% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $11.1M $2.93M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $2.72M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $2.73M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $2.73M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.